Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Biotech
Irish biotech launches with $21M to shuttle RNAi meds to brain
Aerska has launched with $21 million to tackle the blood-brain barrier and deliver genetic medicines to the brain.
James Waldron
Oct 1, 2025 10:34am
Thermo Fisher debuts protein panel for neurodegeneration R&D
Sep 16, 2025 12:00pm
Galimedix's oral Alzheimer's candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
AC Immune cuts workforce by 30%, trims pipeline to preserve cash
Sep 4, 2025 10:27am
Prothena Alzheimer's trial hit by ARIA showstopper
Aug 28, 2025 6:48am
Lighthouse nabs $49M grant for bacteria-related Alzheimer's test
Aug 22, 2025 8:07am
